Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

0.0%

-86.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

Phase 4
2(66.7%)
N/A
1(33.3%)
3Total
Phase 4(2)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07385313Phase 4Recruiting

Combined OFM and Vacuum-assisted Therapy for Expedited Regeneration Over Structures

Role: collaborator

NCT05780918Not ApplicableActive Not Recruiting

A Communication Tool to Improve Communication in the ICU

Role: collaborator

NCT07218185Not Yet Recruiting

Comparative Effectiveness of INTERCEPT Fibrinogen Complex (IFC) and Cryoprecipitate-AHF (Cryo-AHF) for Treatment of Trauma Associated Hemorrhage

Role: collaborator

NCT04681638Phase 4Terminated

Plasma Resuscitation Without Lung Injury

Role: lead

All 4 trials loaded